SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2483You're asking the wrong guy. See discussion over here: Message 23963108 atuck-10/13/2007
2482What's the most likely scenario for the fate of Tysabri if BIIB is sold? WSidney Street-10/13/2007
2481<i>For now, Stoll said his team is focused on trying to "define the bIcebrg-10/13/2007
2480Biogen for sale? Interesting Friday afternoon bombshell: >>Biogen Idec Ituck-10/12/2007
2479Dream......or delude selves! JonRobohogs-10/12/2007
2478Or CEOs can dream of taking the platform all the way to an NDA...nigel bates-10/12/2007
2477If pharmas know this and bluff, offering a lower price, the companies may be forRobohogs-10/11/2007
2476gimv.com These guys have some good bio's in their portfolio that we like budr.praveen-10/11/2007
2475>>Maybe a stupid question, but why wouldn't a takeover benefit both patuck-10/11/2007
2474tuck; Maybe a stupid question, but why wouldn't a takeover benefit both parSteve Lokness-10/11/2007
2473Simply suggesting that if Biolex and Ablynx make it onto the public markets, thetuck-10/11/2007
2472Are you predicting that it will be munched before the public see's a single Ian@SI-10/11/2007
2471Ablynx, which the IN VIVO blogsters identified as a takeout candidate, just filetuck-10/11/2007
2470Thanks for your note this AM, I probably would have missed the buyout for a couppgo-neil-10/11/2007
2469Bioenvision Demands a Recount By Brian Lawler October 10, 2007 - The Motley Fooltnsaf-10/10/2007
2468Trying to figure out Dara is tough. Not much out their on their funding. Seems lrkrw-10/10/2007
2467"Chomp! Wyeth Snaps Up Haptogen" invivoblog.blogspot.com This blogpotuck-10/9/2007
2466FOCUS Sanofi-Aventis surges on Pfizer interest rumour; analysts sceptical 9/10/2sim1-10/9/2007
2465PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell SnowShredder-10/1/2007
2464Finally! (except I don't own any any more!)tom pope-10/1/2007
2463PDLI fires CEO and puts itself up for sale. Conf Call at 4:30? or trading resumIan@SI-10/1/2007
2462Drug company M&A Monday October 1, 6:15 am ET Unless something changes, theIcebrg-10/1/2007
2461Bristol-Myers Squibb to Acquire Adnexus Therapeutics Monday September 24, 9:01 anigel bates-9/24/2007
2460>>Roche Gets OK From German Agency On Ventana Proposed Buy Last update: 9/tuck-9/21/2007
2459Potential munch for those with access to London... <b>Bespak Shares Rise Ian@SI-9/21/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News